Clinical Trial Update: Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating an intercostal nerve block with HR18034 for postsurgical pain management following thoracoscopic lobectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Surgery Postoperative Pain
• Thoracoscopic Lobectomy-related Postoperative Pain

Drugs mentioned

• HR18034

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Thoracoscopic Lobectomy | Phase 2 | Status: UNKNOWN